MX2009011494A - Marcadores de enfermedades. - Google Patents

Marcadores de enfermedades.

Info

Publication number
MX2009011494A
MX2009011494A MX2009011494A MX2009011494A MX2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A
Authority
MX
Mexico
Prior art keywords
disease markers
autoimmune disease
subject
biomarkers
leukocytes
Prior art date
Application number
MX2009011494A
Other languages
English (en)
Inventor
David Wraith
Original Assignee
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Ltd filed Critical Apitope Technology Bristol Ltd
Publication of MX2009011494A publication Critical patent/MX2009011494A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a biomarcadores para enfermedades autoinmunitarias, y en particular, a un método para la determinación del estado de una enfermedad autoinmunitaria en un sujeto de ensayo, que comprende la medición de la producción de una citoquina Th2 por leucocitos del sujeto; al igual que a usos y equipos asociados.
MX2009011494A 2007-04-24 2008-04-23 Marcadores de enfermedades. MX2009011494A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0707933.8A GB0707933D0 (en) 2007-04-24 2007-04-24 Disease markers
PCT/GB2008/001415 WO2008129296A2 (en) 2007-04-24 2008-04-23 Disease markers

Publications (1)

Publication Number Publication Date
MX2009011494A true MX2009011494A (es) 2009-11-09

Family

ID=38135366

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011494A MX2009011494A (es) 2007-04-24 2008-04-23 Marcadores de enfermedades.

Country Status (13)

Country Link
US (1) US20100129853A1 (es)
EP (1) EP2156190A2 (es)
JP (1) JP2010525355A (es)
CN (1) CN102317787A (es)
AU (1) AU2008240367A1 (es)
BR (1) BRPI0810559A2 (es)
CA (1) CA2685113A1 (es)
GB (1) GB0707933D0 (es)
MX (1) MX2009011494A (es)
NO (1) NO20093384L (es)
PL (1) PL391035A1 (es)
RU (1) RU2009142935A (es)
WO (1) WO2008129296A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
KR20220008944A (ko) 2008-01-18 2022-01-21 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
GB0903391D0 (en) * 2009-02-27 2009-04-08 Cambridge Entpr Biomarkers
EP2539470B1 (en) * 2010-02-24 2017-02-22 The Board of Trustees of The Leland Stanford Junior University Methods for autoimmune disease diagnosis, prognosis, and treatment
JP2013538565A (ja) 2010-07-23 2013-10-17 プレジデント アンド フェロウズ オブ ハーバード カレッジ 体液中の疾患または症状のシグネチャを検出する方法
WO2012012725A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
US20130184178A1 (en) 2010-07-23 2013-07-18 President And Fellows Of Harvard College Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
GB201400562D0 (en) 2014-01-14 2014-03-05 Orla Protein Technologies Ltd Protein coated polymeric substrate
EP3191846A4 (en) 2014-09-11 2018-06-13 Harry Stylli Methods of detecting prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1546719E (pt) * 2002-08-08 2015-07-02 Baylor College Medicine Isolamento e identificação de células t
ATE491953T1 (de) * 2003-09-15 2011-01-15 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis

Also Published As

Publication number Publication date
WO2008129296A2 (en) 2008-10-30
CN102317787A (zh) 2012-01-11
AU2008240367A1 (en) 2008-10-30
BRPI0810559A2 (pt) 2015-02-10
WO2008129296A3 (en) 2008-12-11
RU2009142935A (ru) 2011-05-27
JP2010525355A (ja) 2010-07-22
PL391035A1 (pl) 2010-10-25
US20100129853A1 (en) 2010-05-27
GB0707933D0 (en) 2007-05-30
NO20093384L (no) 2010-01-18
CA2685113A1 (en) 2008-10-30
EP2156190A2 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
MX2009011494A (es) Marcadores de enfermedades.
MX2014003153A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
MX340453B (es) Biomarcadores para cancer de pulmon.
NZ606725A (en) Methods for predicting anti-cancer response
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
EA201590027A1 (ru) Способы детекции заболеваний или состояний
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
MX2015006680A (es) Composiciones y metodos para diagnosticar tumores de tiroides.
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
ATE438856T1 (de) Biomarker für eierstockkrebs: mit ctap3 verwandte proteine
WO2011128357A3 (en) Biomarkers for hypertensive disorders of pregnancy
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
WO2013052505A3 (en) Methods and devices for assessing risk to a putative offspring of developing a condition
MX2009011007A (es) Biomarcadores para esclerosis multiple.
WO2010068686A3 (en) Methods of diagnosing and predicting renal disease
CY1111811T1 (el) Μεθοδοι ms για την αξιολογηση γλυκανων
WO2012096545A3 (ko) 췌장암 암줄기세포 특성을 이용한 췌장암 신규 바이오마커 및 그의 용도
WO2015067969A3 (en) Method, array and use thereof for determining pancreatic cancer
WO2011085163A3 (en) Protein markers for lung cancer detection and methods of using thereof
WO2011106709A3 (en) Epithelial biomarkers for cancer prognosis
HK1165001A1 (zh) 利用免疫法測定生物樣品中的雌馬酚的方法、用於該測定的試劑盒、以及判定受試者的雌馬酚產生能力的方法
WO2010087594A3 (ko) 시디９３ 또는 이의 가용성 단편의 용도
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
GB201014837D0 (en) Biomarker signatures and uses thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal